Atlas Trials

A Study of SPY072 in Rheumatic Disease

Clinical trial NCT07148414 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07148414
Sponsor
Spyre Therapeutics, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Rheumatoid ArthritisPsoriatic ArthritisAxial SpondyloarthritisRheumatic DiseasesRheumatic Joint DiseasePsA (Psoriatic Arthritis)AxSpARheumatologic Disease
Start date
2025-08-21
Primary completion
2026-10-31
Enrollment
285

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.